20 years from now patent protection will be long g
Post# of 148184
Remember, this is a biotech not Coca Cola. And a $1000 sp would be $100 billion in revenue even at a stretched multiple of 7. That's total revenue, not Cytodyn's. We don't know what Cytodyn's piece of the pie for various indications will be, maybe 40%. So total revenue would have to be $250 billion, which is really pie in the sky.
If we hit $20 billion total revenue in x amount of years that would work out to a $50 sp at 8 million shares outstanding which would be more than I could hope for even being an ardent believer in the science for over a year and a half.